Nalaganje...

Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism

OBJECTIVE: We evaluated the metabolic effects and tolerability of GFT505, a novel dual peroxisome proliferator–activated receptor α/δ agonist, in abdominally obese patients with either combined dyslipidemia or prediabetes. RESEARCH DESIGN AND METHODS: The S1 study was conducted in 94 patients with c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cariou, Bertrand, Zaïr, Yassine, Staels, Bart, Bruckert, Eric
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2011
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161281/
https://ncbi.nlm.nih.gov/pubmed/21816979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-0093
Oznake: Označite
Brez oznak, prvi označite!